Exact Mass: 275.1481136

Exact Mass Matches: 275.1481136

Found 76 metabolites which its exact mass value is equals to given mass value 275.1481136, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

epsilon-(gamma-Glutamyl)lysine

(2S)-2-amino-6-[(4S)-4-amino-4-carboxybutanamido]hexanoic acid

C11H21N3O5 (275.1481136)


In non-diabetic kidney scarring the protein crosslinking enzyme tissue transglutaminase (tTg) has been implicated in the process by the formation of increased epsilon-(gamma-glutamyl)lysine bonds between ECM components in both experimental and human disease. Changes in tTg and epsilon-(gamma-glutamyl)lysine occur in human Diabetic nephropathy as well, the leading cause of chronic kidney failure. (PMID 15292688). In Parkinsons disease (PD), conformational changes in the alpha-synuclein monomer precede the formation of Lewy bodies. Both tTG and its substrate-characteristic N(epsilon)-(gamma-glutamyl)-lysine crosslink are increased in PD nigral dopamine neurons. (PMID 15001552). Expression of tissue transglutaminase (tTgase) and epsilon-(gamma-glutamyl)-lysine was present in all scarring of the blebs sites, being the main cause of failure in glaucoma filtration surgery. Transglutaminases are calcium-dependent enzymes that catalyze the posttranslational modification of proteins through an acyl transfer reaction between the gamma-carboxamide group of a peptide-bound glutaminyl residue and various amines. Covalent cross-linking using epsilon-(gamma-glutamyl)-lysine bonds is stable and resistant to enzymatic, chemical, and mechanical disruption. (PMID: 16936095). In non-diabetic kidney scarring the protein crosslinking enzyme tissue transglutaminase (tTg) has been implicated in the process by the formation of increased epsilon-(gamma-glutamyl)lysine bonds between ECM components in both experimental and human disease. Changes in tTg and epsilon-(gamma-glutamyl)lysine occur in human Diabetic nephropathy as well, the leading cause of chronic kidney failure. (PMID 15292688)

   

2-Acetamido-4-(D-alanylamino)-2,4,6-trideoxy-D-mannopyranose

2-Acetamido-4-(D-alanylamino)-2,4,6-trideoxy-D-mannopyranose

C11H21N3O5 (275.1481136)


   

gamma-Glutamyllysine

(2S)-6-Amino-2-{[(4S)-4-amino-4-carboxy-1-hydroxybutylidene]amino}hexanoate

C11H21N3O5 (275.1481136)


gamma-Glutamyllysine is a dipeptide composed of gamma-glutamate and lysine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. gamma-Glutamyllysine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Lysylglutamic acid

(2S)-2-[(2S)-2,6-diaminohexanamido]pentanedioic acid

C11H21N3O5 (275.1481136)


Lysylglutamic acid is a dipeptide composed of lysine and glutamic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutamyllysine

(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanoic acid

C11H21N3O5 (275.1481136)


Glutamyllysine is a dipeptide composed of glutamate and lysine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamyllysine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. The absorption of glutamyllysine is facilitated by the human intestinal oligopeptide transporter (PEPT1) (PMID 16759105). Glutamyl-L-lysine is a dipeptide whose absorption is facilitated by the human intestinal oligopeptide transporter (PEPT1) (PMID 16759105).

   

epsilon-(gamma-Glutamyl)-L-lysine

2,6,10-triamino-5-oxoundecanedioic acid

C11H21N3O5 (275.1481136)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Ε-(γ-glu)-LYS

Ε-(γ-glutamyl)lysine isodipeptide

C11H21N3O5 (275.1481136)


   

Glutamyllysine

N2-L-alpha-Glutamyl-lysine

C11H21N3O5 (275.1481136)


   
   
   

5-oxo-DL-proline, compound with DL-lysine (1:1)

5-oxo-DL-proline, compound with DL-lysine (1:1)

C11H21N3O5 (275.1481136)


   

L-Serine, glycyl-L-leucyl-

L-Serine, glycyl-L-leucyl-

C11H21N3O5 (275.1481136)


   

L-lysyl-D-glutamic acid

L-lysyl-D-glutamic acid

C11H21N3O5 (275.1481136)


   

lysylglutamic acid, Lys-Glu, H-LYS-GLU-OH, Peptide vilon

lysylglutamic acid, Lys-Glu, H-LYS-GLU-OH, Peptide vilon

C11H21N3O5 (275.1481136)


   

epsilon-(gamma-Glutamyl)-L-lysine

2,6,10-triamino-5-oxoundecanedioic acid

C11H21N3O5 (275.1481136)


   

Lysylglutamic acid

Lysylglutamic acid

C11H21N3O5 (275.1481136)


D020011 - Protective Agents

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

epsilon-(gamma-Glutamyl)lysine

epsilon-(gamma-Glutamyl)-lysine

C11H21N3O5 (275.1481136)


An N(6)-acyl-L-lysine derivative in which the acyl group is specified as gamma-glutamyl.

   

epsilon-(gamma-L-Glutamyl)-L-lysine

epsilon-(gamma-L-Glutamyl)-L-lysine

C11H21N3O5 (275.1481136)


   

Lys-glu

Lys-glu

C11H21N3O5 (275.1481136)


A dipeptide formed from L-lysine and L-glutamic acid residues.

   

Glu-Lys

H-Glu-Lys-OH

C11H21N3O5 (275.1481136)


A dipeptide composed of L-glutamic acid and L-lysine joined by a peptide linkage.

   

Gamma-glutamyl-Lysine

Gamma-glutamyl-Lysine

C11H21N3O5 (275.1481136)


   

epsilon-(gamma-glutamyl)lysine dizwitterion

epsilon-(gamma-glutamyl)lysine dizwitterion

C11H21N3O5 (275.1481136)


An L-alpha-amino acid zwitterion that is the dizwitterionic form of epsilon-(gamma-glutamyl)lysine obtained by migration of protons from both carboxy groups to the amino groups; major species at pH 7.3.

   
   

(2s)-6-amino-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}hexanoic acid

(2s)-6-amino-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}hexanoic acid

C11H21N3O5 (275.1481136)


   

6-amino-2-[(4-amino-4-carboxy-1-hydroxybutylidene)amino]hexanoic acid

6-amino-2-[(4-amino-4-carboxy-1-hydroxybutylidene)amino]hexanoic acid

C11H21N3O5 (275.1481136)